 | Up a level |
McEwan, Phil, Bennett, Hayley, Khunti, Kamlesh, Wilding, John 
ORCID: 0000-0003-2839-8404, Edmonds, Christopher, Thuresson, Marcus, Wittbrodt, Eric, Fenici, Peter and Kosiborod, Mikhail
(2020)
Assessing the cost-effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus: A comprehensive economic evaluation using clinical trial and real-world evidence.
DIABETES OBESITY & METABOLISM, 22 (12).
pp. 2364-2374.
McEwan, Phil, Morgan, Angharad R, Boyce, Rebecca, Bergenheim, Klas, Gause-Nilsson, Ingrid AM, Bhatt, Deepak L, Leiter, Lawrence A, Johansson, Peter A, Mosenzon, Ofri, Cahn, Avivit et al (show 1 more authors)
(2021)
The cost-effectiveness of dapagliflozin in treating high-risk patients with type 2 diabetes mellitus: An economic evaluation using data from the DECLARE-TIMI 58 trial.
DIABETES OBESITY & METABOLISM, 23 (4).
pp. 1020-1029.